NOV 14, 2018 08:48 AM PST

How Cancer's 'Invisibility Cloak' Works

WRITTEN BY: Xuan Pham

One of cancer’s cunning strategies to evade death is to make itself invisible to the immune system. Now researchers say they’ve identified the key to how cancer’s “invisibility cloak” works. This discovery promises to bring other therapeutic targets to prevent cancer from metastasizing at will.

Cancer has an 'invisibility cloak' and scientists now know how it works | Image: pixabay.com

Despite the seemingly endless barrage of news of diseases and sickness, the human body is actually quite remarkable at keeping us healthy and well. The immune system plays a crucial role in this regard, fending off external and internal attacks to our health. However, the immune system can only fight what it can “see” or recognize.

By lurking in stealth mode, some cancers are able to bypass the immune system to flourish and take over the body. "The immune system is efficient at identifying and halting the emergence and spread of primary tumors but when metastatic tumors appear, the immune system is no longer able to recognize the cancer cells and stop them," said Wilfred Jefferies, senior author of the study at the University of British Columbia.

But how does cancer make itself invisible to our defenses? As it turns out, expression of a key protein is necessary for recognition by the immune system. Specifically, when cancer cells mutate to lose the protein known as interleukein-33, or IL-33, our immune cells can’t tell that the cells are cancerous.
 


"We discovered a new mechanism that explains how metastatic tumors can outsmart the immune system and we have begun to reverse this process so tumors are revealed to the immune system once again,” said Jefferies.

In particular, loss of IL-33 seems to occur with epithelial carcinomas – cancers that start on the surface of organs and tissues like prostate, kidney, lung, and breast. In studying several hundred patients, the team found that loss of IL-33 in prostate or kidney cancer patients was associated with higher cancer recurrence rate. This implies that IL-33 loss offers a sort of cover for cancer cells to hang around undeterred by the immune system.

"IL-33 could be among the first immune biomarkers for prostate cancer and, in the near future, we are planning to examine this in a larger sample size of patients," said Iryna Saranchova, the first author of the study. Already, experiments to turn back IL-33 seem to strip the tumors of their ‘invisibility cloak’ and make them vulnerable to immune system attacks.
 
Additional source: University of British Columbia

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Effective Treatment for Ulveal Melanoma
Uveal melanoma is a rare and aggressive type of melanoma that targets the eye and affects an estimated 2,500 people in the United States annually. Nearly h...
OCT 19, 2019
Cancer
OCT 19, 2019
Could electromagnetic fields treat metastatic triple-negative breast cancer?
New research published in Communications Biology suggests that electromagnetic fields are capable of stopping the metastasis of some breast cancer cells. I...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Insulin Drug Could Treat Glioblastoma
A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold...
OCT 19, 2019
Cancer
OCT 19, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
OCT 19, 2019
Cancer
OCT 19, 2019
Gut fungi linked to pancreatic cancer
In a recent paper published in Nature paper, researchers from the New York University (NYU) School of Medicine in NYC report that gut fungi may be lin...
OCT 19, 2019
Cancer
OCT 19, 2019
Looking to the depths of the human genome to understand cancer
Have you ever heard of dark matter? No, I’m not talking about the dark matter of the universe – I mean the dark matter that lives within your g...
Loading Comments...